Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Community Implementation of KEEP: Fidelity and Generalization of Parenting
Community Implementation of KEEP: Fidelity and Generalization of Parenting
Status: Enrolling
Updated:  6/13/2013
Child and Adolescent Services Research Center
mi
from
San Diego, CA
Community Implementation of KEEP: Fidelity and Generalization of Parenting
Community Implementation of KEEP: Fidelity and Generalization of Parenting
Status: Enrolling
Updated: 6/13/2013
Child and Adolescent Services Research Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Brief Intervention for Problem Drinking and Partner Violence
A Randomized Control Trial of Brief Intervention for Problem Drinking and Partner Violence
Status: Enrolling
Updated:  6/17/2013
Emergency Department, Hospital of the University of PA
mi
from
Philadelphia, PA
Brief Intervention for Problem Drinking and Partner Violence
A Randomized Control Trial of Brief Intervention for Problem Drinking and Partner Violence
Status: Enrolling
Updated: 6/17/2013
Emergency Department, Hospital of the University of PA
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Family-Based Treatment for Parental Substance Abuse and Child Maltreatment
Family-Based Treatment for Parental Substance Abuse and Child Maltreatment
Status: Enrolling
Updated:  6/17/2013
Connecticut Department of Children and Families
mi
from
New Britain, CT
Family-Based Treatment for Parental Substance Abuse and Child Maltreatment
Family-Based Treatment for Parental Substance Abuse and Child Maltreatment
Status: Enrolling
Updated: 6/17/2013
Connecticut Department of Children and Families
mi
from
New Britain, CT
Click here to add this to my saved trials
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated:  6/25/2013
Valley Medical Center
mi
from
Renton, WA
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Valley Medical Center
mi
from
Renton, WA
Click here to add this to my saved trials
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated:  6/25/2013
Harborview Medical Center
mi
from
Seattle, WA
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated:  6/25/2013
Swedish Medical Center
mi
from
Seattle, WA
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated:  6/25/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated:  6/25/2013
University of Washington Medical Center
mi
from
Seattle, WA
ICU Family Communication Study
A Randomized Trial of an Interdisciplinary Communication Intervention to Improve Patient and Family Outcomes in the Intensive Care Unit
Status: Enrolling
Updated: 6/25/2013
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
Status: Enrolling
Updated:  6/25/2013
Behavioral Health Services
mi
from
Los Angeles, CA
An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents
Status: Enrolling
Updated: 6/25/2013
Behavioral Health Services
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
Treatment of Cancer Anorexia-cachexia Syndrome (CACS) With Mirtazapine and Megestrol Acetate
Status: Enrolling
Updated:  6/28/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
Treatment of Cancer Anorexia-cachexia Syndrome (CACS) With Mirtazapine and Megestrol Acetate
Status: Enrolling
Updated: 6/28/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder
Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder
Status: Enrolling
Updated:  7/1/2013
Boston Med Center
mi
from
Boston, MA
Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder
Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder
Status: Enrolling
Updated: 7/1/2013
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Pharmacology Research Institute
mi
from
Newport Beach, CA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Collaborative Neuroscience Network Inc
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
University of California, Irvine
mi
from
Irvine, CA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Excell Research, Inc.
mi
from
Oceanside, CA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Accurate Clinical Trials
mi
from
Kissimmee, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Accurate Clinical Trials
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Florida Research Center
mi
from
Maitland, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Florida Research Center
mi
from
Maitland, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Miami Research Associates
mi
from
South Miami, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Research Centers of America, LLC
mi
from
Oakland Park, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Research Centers of America, LLC
mi
from
Oakland Park, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
iResearch Atlanta LLC
mi
from
Decatur, GA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
IPS Research Company
mi
from
Oklahoma City, IN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
IPS Research Company
mi
from
Oklahoma City, IN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Rochester Center for Behavioral Health
mi
from
Rochester Hills, MI
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Rochester Center for Behavioral Health
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Midwest Research Group
mi
from
St. Charles, MO
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Brooklyn Medical Institutes, LLC
mi
from
Brooklyn, NY
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Brooklyn Medical Institutes, LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
NYU School of Medicine
mi
from
New York, NY
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Duke Child and Family Study Center
mi
from
Durham, NC
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Suburban Research Associates
mi
from
Media, PA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
CRI Lifetree
mi
from
Philadelphia, PA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
CRI Lifetree
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Future Search Clinical Trials, LP
mi
from
Austine, TX
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Future Search Clinical Trials, LP
mi
from
Austine, TX
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
NeuroScience, Inc.
mi
from
Herndon, VA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Baltimore, MD
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Boston, MA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Jackson, MS
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Assess OX219 (Buprenorphine/Naloxone) for the Induction of Treatment of Opioid Dependence
A Randomized, Blinded, Active-controlled Non-inferiority Study of the Efficacy and Safety of OX219 for the Induction of Treatment of Opioid Dependence
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials